Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON49422Completed
Trial of human insulin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Leiden University. Primary endpoints: Blood insulin levels during evocation day and Blood glucose levels during evocation day. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON49422.